Dopamine receptor antagonists as potential therapeutic agents for ADPKD
نویسندگان
چکیده
منابع مشابه
Orexin receptor antagonists as therapeutic agents for insomnia
Insomnia is a common clinical condition characterized by difficulty initiating or maintaining sleep, or non-restorative sleep with impairment of daytime functioning. Currently, treatment for insomnia involves a combination of cognitive behavioral therapy (CBTi) and pharmacological therapy. Among pharmacological interventions, the most evidence exists for benzodiazepine (BZD) receptor agonist dr...
متن کاملTherapeutic potential of selective D-1 dopamine receptor agonists and antagonists in psychiatry and neurology.
Recent reviews have documented the rapid change in the perceived role of the D-1 dopamine (DA) receptor, from a neurochemical entity of obscure functional relevance (other than the stimulation of adenylate cyclase activity) to a physiological unit of apparently prominent behavioural significance (Waddington, 1986a; Breese and Creese, 1986; Waddington and O'Boyle, 1988). Selective D-1 agonists a...
متن کاملDopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases
D3 receptors represent a major focus of current drug design and development of therapeutics for dopamine-related pathological states. Their close homology with the D2 receptor subtype makes the development of D3 selective antagonists a challenging task. In this review, we explore the relevance and therapeutic utility of D3 antagonists or partial agonists endowed with multireceptor affinity prof...
متن کاملCRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases
Accumulation of type 2 T helper (Th2) lymphocytes and eosinophils is a hallmark of bronchial asthma and other allergic diseases, and it is believed that these cells play a crucial pathogenic role in allergic inflammation. Thus, Th2 cells and eosinophils are currently considered a major therapeutic target in allergic diseases and asthma. However, drugs that selectively target the accumulation an...
متن کاملCRTH2 and D-Type Prostanoid Receptor Antagonists as Novel Therapeutic Agents for Inflammatory Diseases
Accumulation of type 2 T helper (Th2) lymphocytes and eosinophils is a hallmark of bronchial asthma and other allergic diseases, and it is believed that these cells play a crucial pathogenic role in allergic inflammation. Thus, Th2 cells and eosinophils are currently considered a major therapeutic target in allergic diseases and asthma. However, drugs that selectively target the accumulation an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLOS ONE
سال: 2019
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0216220